{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Arcitumomab",
  "nciThesaurus": {
    "casRegistry": "154361-48-5",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A murine IgG monoclonal Fab' fragment antibody directed against carcinoembryonic antigen (CEA), a protein that is overexpressed by many tumor cell types. For tumors that overexpress CEA, technetium-99m labeled arcitumomab may be used as an adjunct diagnostic imaging tool to obtain prognostic information following resection and to monitor for recurrent disease.",
    "fdaUniiCode": "79T6JRG308",
    "identifier": "C1494",
    "preferredName": "Arcitumomab",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C20401"
    ],
    "synonyms": [
      "ARCITUMOMAB",
      "Arcitumomab",
      "CEA-Scan",
      "IMMU-4",
      "Immunoglobulin G 1 (mouse monoclonal IMMU-4 Fab' fragment gamma-chain anti-human antigen CEA), disulfide with mouse Monoclonal IMMU-4 Light Chain"
    ]
  }
}